BioTrinity hits new record: 880+ delegates from 28 countries attended

 

BioTrinity 2013 - European Biopartnering and Investment Conference - May 14-16, 2013


Where Great Minds and Smart Money meet Under One Roof

View our 45 seconds BioTrinity trailer

BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other European partnering conference. Check out who else is coming, we expect about 850 delegates including nearly 80 investment firms, hear what delegates say about BioTrinity, the expert discussion panels, and which 90 companies will be presenting in the showcase. Don't miss out: 

 Meet the key licensing contacts from big pharma including AbbVie, Amgen, AstraZeneca, Boehringer,  Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GE, GSK, Ipsen, J&J, Janssen R&D, Linde Healthcare, MSD, Novartis, Novo Nordisk, Shire, Pfizer, Takeda, Teijin, UCB as well as Vertex, Genus, EUSA, Nordic Pharma, Mercury and other senior BD&L execs

 Meet 100 delegates from active VC and Corporate Venture firms including MedImmune Ventures, SR One, Shire Strategic Investment, AbbVie Biotech Ventures, Mitsui & Co.MPHVM, Norgine Investment Fund, Novartis Venture Fund, Takeda Ventures, Boehringer Ingelheim Ventures, Inventages, Amorepacific Ventures as well as Syncona, Index, Sofinnova and many international VCs

 Meet a hand-picked crop of early-stage companies you haven't seen elsewhere

 Meet the senior execs who can complete the value chain for your business

...Deploying EBD Group's partneringONE®, the industry gold-standard partnering system with entirely private partnering: 

partneringOne

You need to upgrade your Flash Player


The "Event of the Year" - BioTrinity 2013:

Huge partnering potential with global pharma / investors

 90 presentations by hand-picked R&D companies

Great networking opportunities with 850 delegates projected

 First class venue at Newbury Racecourse

Exciting Social Programme:

 Grand Opening Reception and Gala Dinner

 Europe's Largest Investor-only Dinner

Check out the glowing testimonials we received for BioTrinity, or view the photos from the Gallery



BioTrinity 2012 highlights
800 delegates from 26 countries
500 companies
130 speakers
75 company presentations
1850 scheduled one-to-one meetings
80 investors from 10 countries
69 exhibitors
22 global pharma